Dual Action
NovoMix® – an insulin analogue mix
NovoMix® 30 is a dual-release formulation of free soluble and protaminated
insulin aspart
Free, soluble insulin aspart is rapidly absorbed to address prandial insulin needs
Protaminated insulin aspart is released more slowly, having a longer duration of action
NovoMix® 30 has a pharmacokinetic profile that mimics normal prandial insulin physiology
Postprandial control with NovoMix® 30 is superior to biphasic human insulin 30 (BHI 30)
Dose-for-dose, NovoMix® 30 has a greater glucose-lowering effect than insulin glargine